Intrapleural talc for the treatment of m
โ
Ribas C. Milanez; Francisco S. Vargas; Luiz B. Filomeno; Lisete R. Teixeira; Ang
๐
Article
๐
1995
๐
John Wiley and Sons
๐
English
โ 448 KB
๐ 2 views
Background. The management of malignant pleural effusions secondary to breast cancer is a difficult problem. In the 1980s tetracycline was probably the most commonly used sclerosing agent, but parenteral tetracycline is no longer available. Therefore, it is important to evaluate alternative sclerosi